Novartis Partners with SHYFT

Published on: 

Pharmaceutical Executive

SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.

Novartis will use the following SHYFT solutions:


  • STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources

  • LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams